Pharmacoeconomic Modelling:

Our economic modelling service normally forms part of an integrated programme of activities designed to provide robust cost-effectiveness evidence to support regulatory approval for use of the use of technologies.

Decision-analysis models are particularly useful in helping to integrate the results of epidemiology, clinical, health economic and quality of life studies.

Evicom develop models customised to the sophistication of the target audience which may range from regulatory authorities to local healthcare physicians.

Our models are developed using a range of software to best suite the needs of the target audience. For transparency and accessibility we recommend development in excel with visual basic programming where necessary.

Our models will normally include:

• Discounting of future outcome benefits and costs
• Incremental costs-effectiveness or cost-utility ratios
• Sensitivity analyses
• Budget impact
• Service impact

Most of our programs are designed to be self explanatory with simple step-by-step instructions and help support.

Where necessary we provide training to help in the understanding and communication of these models.